MedTrace Logo

Expression of Tuberculosis in the Lung

NCT00201253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-01-26

No results posted yet for this study

Summary

The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.

Conditions

Interventions

OTHER

Bronchoalveolar lavages and venipunctures only

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Jerrold Ellner · UMDNJ-New Jersey Medical School

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201253 on ClinicalTrials.gov